Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Clinical Medicine Insights. Endocrinology and Diabetes|May 2, 2019
Considerations for Thyroidectomy as Treatment for Graves DiseaseMary Smithson, Ammar Asban, Jason Miller, et al.The Journal of Surgical Research|July 11, 2022
Pearls and Pitfalls for Surgical Investigators in Basic and Translational ResearchVikas Dudeja, Mary Smithson, Herbert Chen, et al.Heliyon|May 6, 2022
Using the H-index as a factor in the promotion of surgical facultyRongzhi Wang, Marshall Lewis, Rui Zheng-Pywell, et al.Surgery|December 1, 2024
Expedited discharge and risk of readmission after ostomy constructionKaitlin G Burge, Hannah Ficarino Sheffer, Mary Smithson, et al.Research Square|July 16, 2024
Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerZechen Chong, Fengyuan Huang, M McLeod, et al.The Journal of Surgical Research|May 11, 2021
NIH Funding of Researchers in Surgery: Decreased Career Development Awards Over TimeMary Smithson, M Chandler McLeod, Dan I Chu, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|October 7, 2021
Ileostomy Patients Using Patient Engagement Technology Experience Decreased Length of StayMary Smithson, M Chandler McLeod, Lauren Theiss, et al.Neoplasia (New York, N.Y.)|March 11, 2024
ST6GAL1 is associated with poor response to chemoradiation in rectal cancerMary Smithson, Sameer Al Diffalha, Regina K Irwin, et al.Cancer Genomics & Proteomics|January 2, 2026
Exosomes Transfer ST6GAL1-mediated Therapeutic Resistance in Rectal Cancer CellsJeremie M P Lever, Regina K Irwin, Vivek Somasundaram, et al.The Journal of Biological Chemistry|January 18, 2022
Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancerMary Smithson, Regina Irwin, Gregory Williams, et al.Pageof 2